Symbols / NURO
NURO Chart
About
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain. The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | — |
| Enterprise Value | -3.55M | Income | -7.81M | Sales | 3.03M |
| Book/sh | — | Cash/sh | 6.36 | Dividend Yield | — |
| Payout | 0.00% | Employees | 13 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | 0.44 | EV/Sales | -1.17 | Quick Ratio | 13.12 |
| Current Ratio | 14.83 | Debt/Eq | 0.75 | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -55.80% | Earnings | 2020-01-28 06:00 | ROA | -27.90% |
| ROE | -45.38% | ROIC | — | Gross Margin | 56.42% |
| Oper. Margin | -3.36% | Profit Margin | -257.39% | Shs Outstand | — |
| Shs Float | 1.52M | Short Float | 0.12% | Short Ratio | 0.52 |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | 1.83 | Avg Volume | — | Volume | — |
| Target Price | — | Recom | None | Prev Close | $0.00 |
| Price | $4.58 | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$4.58
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$4.58
Low
—
High
—
Mean
—
- Can You Buy Nuro Stock Pre-IPO? What to Know - The Motley Fool hu, 20 Nov 2025 08
- Uber inks six-year robotaxi deal with Lucid, invests $300 million in EV company - CNBC hu, 17 Jul 2025 07
- Lucid Stock Climbs as Gravity SUVs Begin Deliveries to Nuro in Uber Tie-Up - eletric-vehicles.com Wed, 24 Sep 2025 07
- Lucid Takes On Tesla’s Robo-Taxis. Stock Jumps on Self-Driving Partnership With Uber, Nuro. - Barron's hu, 17 Jul 2025 07
- Lucid Stock Soared on News of Robotaxi Partnership With Uber, Nuro—Watch These Key Levels - Investopedia hu, 17 Jul 2025 07
- Uber Stock Falls As Wall Street Sizes Up Robotaxi Deal With Lucid - Investor's Business Daily hu, 17 Jul 2025 07
- Lucid stock skyrockets on multimillion dollar Uber robotaxi deal - Yahoo Finance hu, 17 Jul 2025 07
- Lucid stock rises after delivering first robotaxi vehicle to Nuro - Investing.com Wed, 24 Sep 2025 07
- Meet Nuro: The company right in the middle of the rise of autonomous vehicles - Seeking Alpha Sat, 19 Jul 2025 07
- Lucid Stock Rises After Delivering Robotaxi Vehicle To Nuro For Deployment Into Uber Fleet: Check Out Cantor Fitzgerald’s New Price Target - Stocktwits Wed, 24 Sep 2025 07
- Uber just made its robotaxi play — with a big investment in Lucid - Business Insider hu, 17 Jul 2025 07
- Uber’s new robotaxi deal sends Lucid stock soaring - qz.com hu, 17 Jul 2025 16
- Lucid stock pops 43% after Uber announces robotaxi. What to know about the Tesla rival - USA Today Fri, 18 Jul 2025 07
- This Tesla rival’s stock soars as Uber plans big investment, launch of robotaxi service - MarketWatch hu, 17 Jul 2025 07
- Lucid (LCID) shares surged +50%, so why did it announce a major reverse stock split? - Electrek hu, 17 Jul 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 469 | 2068 | — | Conversion of Exercise of derivative security at price 4.41 per share. | HIGGINS THOMAS J | Director | — | 2025-04-01 00:00:00 | D |
| 1 | 625 | 2756 | — | Conversion of Exercise of derivative security at price 4.41 per share. | GOZANI SHAI N | Director | — | 2025-04-01 00:00:00 | D |
| 2 | 6369 | — | — | Stock Award(Grant) at price 0.00 per share. | HOROWITZ JOSHUA S | Director | — | 2025-02-03 00:00:00 | D |
| 3 | 6369 | 25920 | — | Stock Award(Grant) at price 0.00 - 4.32 per share. | HOROWITZ JOSHUA S | Director | — | 2025-02-03 00:00:00 | D |
| 4 | 498 | 2146 | — | Conversion of Exercise of derivative security at price 4.31 per share. | HIGGINS THOMAS J | Director | — | 2025-01-31 00:00:00 | D |
| 5 | 636 | 2741 | — | Conversion of Exercise of derivative security at price 4.31 per share. | GOZANI SHAI N | Director | — | 2025-01-31 00:00:00 | D |
| 6 | 469 | 1862 | — | Conversion of Exercise of derivative security at price 3.97 per share. | HIGGINS THOMAS J | Director | — | 2024-12-31 00:00:00 | D |
| 7 | 625 | 2481 | — | Conversion of Exercise of derivative security at price 3.97 per share. | GOZANI SHAI N | Director | — | 2024-12-31 00:00:00 | D |
| 8 | 498 | 1992 | — | Conversion of Exercise of derivative security at price 4.00 per share. | HIGGINS THOMAS J | Chief Financial Officer | — | 2024-11-01 00:00:00 | D |
| 9 | 636 | 2544 | — | Conversion of Exercise of derivative security at price 4.00 per share. | GOZANI SHAI N | Chief Executive Officer | — | 2024-11-01 00:00:00 | D |
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for NURO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|